Geneos Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.6K | Sell |
238
-221
| -48% | -$72.1K | ﹤0.01% | 1359 |
|
|
2025
Q1 | $124K | Buy |
459
+412
| +877% | +$111K | ﹤0.01% | 1445 |
|
|
2024
Q4 | $11.1K | Hold |
47
| – | – | ﹤0.01% | 2013 |
|
|
2024
Q3 | $12.9K | Buy |
+47
| New | +$12.9K | ﹤0.01% | 1729 |
|
|
2022
Q3 | – | Sell |
-986
| Closed | -$146K | – | 2015 |
|
|
2022
Q2 | $146K | Sell |
986
-679
| -41% | -$101K | 0.01% | 864 |
|
|
2022
Q1 | $271K | Sell |
1,665
-58
| -3% | -$9.44K | 0.01% | 697 |
|
|
2021
Q4 | $292K | Buy |
1,723
+37
| +2% | +$6.27K | 0.01% | 741 |
|
|
2021
Q3 | $324K | Buy |
1,686
+3
| +0.2% | +$577 | 0.01% | 683 |
|
|
2021
Q2 | $288K | Sell |
1,683
-103
| -6% | -$17.6K | 0.01% | 706 |
|
|
2021
Q1 | $251K | Sell |
1,786
-224
| -11% | -$31.5K | 0.01% | 877 |
|
|
2020
Q4 | $276K | Buy |
+2,010
| New | +$276K | 0.01% | 714 |
|
|
2017
Q2 | – | Sell |
-24
| Closed | -$1K | – | 2070 |
|
|
2017
Q1 | $1K | Sell |
24
-18
| -43% | -$750 | ﹤0.01% | 1957 |
|
|
2016
Q4 | $1K | Hold |
42
| – | – | ﹤0.01% | 1921 |
|
|
2016
Q3 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 1741 |
|